Skip to main content

Business Intelligence

By Jeff Lagasse | 04:46 pm | April 04, 2022
The partnership is meant in part to ensure compliance with CMS price transparency rules for insurers.
By Jeff Lagasse | 11:44 am | April 01, 2022
CVS Pharmacy will no longer be a defendant in the Florida opioid lawsuit, scheduled for trial in April.
By Jeff Lagasse | 02:45 pm | March 31, 2022
The group took a pro-merger stance, suggesting there are defects in the models used by the FTC to gauge merger appropriateness.
By Jeff Lagasse | 01:03 pm | March 30, 2022
Break into the Boardroom is centered on the philosophy that boardroom diversity is a sound business practice.
By Jeff Lagasse | 04:25 pm | March 29, 2022
The move is a push by Optum and UHG to advance value-based care and expand into the home healthcare market.
HIMSS22
By HIMSS TV | 06:00 am | March 29, 2022
Watch interviews, reports and talks from industry insiders during the second day of the 2022 HIMSS Global Health Conference & Exhibition in Orlando.
By Jeff Lagasse | 05:24 pm | March 28, 2022
The appeals court disagreed with a lower court's ruling that United Behavioral Health's practices were financially motivated.
HIMSS22
By HIMSS TV | 06:00 am | March 28, 2022
Take a look at interviews, reports and insights from industry insiders from day one of the livestream from the 2022 HIMSS Global Health Conference & Exhibition in Orlando.
HIMSS22
By HIMSS TV | 02:00 pm | March 24, 2022
We look at tech advances and key strategies with experts from the 2022 HIMSS Global Health Conference & Exhibition.
By Jeff Lagasse | 04:02 pm | March 23, 2022
Positive results from a Phase 2/3 study suggest the vaccine is safe and effective in younger populations, with few adverse events reported.